The inability of COVID vaccines to reach the long-lived plasma cell compartment in the bone marrow may explain their waning ...

And these data are really quite interesting and impressive that if you don't progress and that your time on [enfortumab ...

Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

WASHINGTON -- Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for ...

There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

Plaintiff attorney: My responsibility is to my client. I need to do the best I can. If the defense demands confidentiality ...

In this week's edition, Mathura shares her firsthand experience and opinions of being in clinic when a Georgia judge ...